Verrucous carcinoma staging

Verrucous carcinoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Verrucous carcinoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Biopsy
Chest X Ray
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Verrucous carcinoma staging On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Verrucous carcinoma staging All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Verrucous carcinoma staging
CDC on Verrucous carcinoma staging
Verrucous carcinoma staging in the news
Blogs on Verrucous carcinoma staging
Directions to Hospitals Treating Verrucous carcinoma
Risk calculators and risk factors for Verrucous carcinoma staging

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Most verrucous carcinomas are nonmetastatic and are staged based on size, as follows:

• T0 lesions - In situ
• T1 lesions - Less than 2 cm in diameter
• T2 lesions - Between 2 and 4 cm in diameter
• T3 lesions - Greater than 4 cm in diameter
• T4 lesions - Invasive of muscle or bone